Correlation between ischemia-modified albumin level and coronary collateral circulation

Xin Chen1, Yan Lin1, Lihua Tian1

  • 1Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, China.

Insights

Higher levels of ischemia-modified albumin (IMA) correlate with good coronary collateral circulation (CCC) formation in patients with chronic total occlusions (CTO). IMA serves as a valuable predictor for assessing CCC in these patients.

Area of Science:

  • Cardiology
  • Biomarkers
  • Vascular Biology

Background:

  • Coronary artery disease (CAD) remains a leading cause of mortality worldwide.
  • Chronic total occlusions (CTO) represent a significant challenge in CAD management.
  • Coronary collateral circulation (CCC) plays a crucial role in mitigating ischemic damage in CTO patients.

Purpose of the Study:

  • To investigate the correlation between ischemia-modified albumin (IMA) levels and the degree of coronary collateral circulation (CCC) in patients with CTO.
  • To evaluate IMA as a potential predictor of good CCC formation in CTO.

Main Methods:

  • A cohort of 128 patients with CTO lesions were analyzed.
  • CCC was assessed using the Rentrop classification system.
  • IMA levels were measured using an albumin-cobalt binding assay.

Main Results:

  • Patients with poor CCC formation had higher platelet counts and diabetes prevalence.
  • Ischemia-modified albumin (IMA) levels were significantly lower in patients with poor CCC.
  • Multivariate analysis revealed IMA as a positive predictor of good CCC formation (OR=1.190, P<0.001).

Conclusions:

  • IMA levels are closely associated with good CCC formation in CTO patients.
  • Elevated IMA levels can effectively predict good CCC development.
  • IMA represents a promising biomarker for assessing collateralization in CTO.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
669
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
280
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
130